CompanyGraph
MicroPort Scientific Corporation
0853 · HKEX · China
Price data from its MSK listing on XSTU, quoted in EUR
microport.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $2.64B, above the global median of $1.15B
- FinancialsAltman Z-Score 0.46: distress zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
20.70BHKD2.64B · vs all stocks (USD)
Revenue (TTM)
8.67BHKD1.11B · vs all stocks (USD)
Profit Margin
4.39%vs Medical Devices peers
Beta
0.3620xvs all stocks
52-Week Change
-50.99%vs all stocks
Market Capitalization
20.70BHKD2.64B · vs all stocks (USD)
Enterprise Value
112.49BHKD14.34B · vs all stocks (USD)
Forward P/E
25.76xvs Medical Devices peers
Price to Sales (TTM)
11.64xvs Medical Devices peers
Price to Book (MRQ)
1.67xvs Medical Devices peers
Enterprise to Revenue
12.97xvs Medical Devices peers
Profit Margin
4.39%vs Medical Devices peers
Operating Margin
-6.76%vs Medical Devices peers
Return on Assets (TTM)
-0.62%vs Medical Devices peers
Return on Equity (TTM)
2.91%vs Medical Devices peers
Revenue (TTM)
8.67BHKD1.11B · vs all stocks (USD)
Revenue per Share (TTM)
0.5900HKDUpdated Aug 19, 2026Quarterly Revenue Growth
18.10%vs Medical Devices peers
Gross Profit (TTM)
4.98BHKD634.81M · vs all stocks (USD)
Net Income (TTM)
380.71MHKD48.54M · vs all stocks (USD)
Operating Cash Flow (TTM)
542.45MHKD69.16M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-1.05BHKD-134.20M · vs all stocks (USD)
5-Year Average Dividend Yield
0.23%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
519.36MUSDFY2025 · Dec 31, 2025Revenue
994.91MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
441.40MUSDFY2025 · Dec 31, 2025Gross Profit
553.51MUSDFY2025 · Dec 31, 2025Operating Income
-54.59MUSDvs all stocks (USD)
Pre-tax Income
-232.49MUSDFY2025 · Dec 31, 2025Income Tax Expense
23.22MUSDFY2025 · Dec 31, 2025Net Income
38.43MUSDFY2025 · Dec 31, 2025EBIT
-125.84MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
65.64MUSDFY2025 · Dec 31, 2025Research & Development
135.50MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
465.65MUSDFY2025 · Dec 31, 2025Other Operating Expenses
26.50MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
14.58MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
106.65MUSDFY2025 · Dec 31, 2025EPS (Basic)
0.0259USDFY2025 · Dec 31, 2025EPS (Diluted)
0.0152USDFY2025 · Dec 31, 2025Basic Shares Outstanding
1.87BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.87BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
76.42MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
10.09MUSDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00USDFY2025 · Dec 31, 2025Operating Cash Flow
104.51MUSDFY2025 · Dec 31, 2025Free Cash Flow
30.48MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
682.51MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
76.42MUSDFY2025 · Dec 31, 2025Stock-based Compensation
35.24MUSDFY2025 · Dec 31, 2025Other Non-cash Items
106.77MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-139.36MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
25.43MUSDFY2025 · Dec 31, 2025Capital Expenditures
-74.02MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-14.94MUSDFY2025 · Dec 31, 2025Net Acquisitions
46.95MUSDFY2025 · Dec 31, 2025Purchase of Investments
-1.05BUSDFY2025 · Dec 31, 2025Sale of Investments
1.03BUSDFY2025 · Dec 31, 2025Other Investing Activity
83.75MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
35.28MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
664.84MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-748.66MUSDFY2025 · Dec 31, 2025Other Financing Charges
99.97MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
7.91MUSDFY2025 · Dec 31, 2025Shares Outstanding
1.91BSharesUpdated Aug 19, 2026Float Shares
996.61MSharesUpdated Aug 19, 2026% Held by Insiders
38.16%vs all stocks
% Held by Institutions
8.99%vs all stocks
Total Cash (MRQ)
6.21BHKD792.13M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.4140HKDUpdated Aug 19, 2026Total Debt (MRQ)
12.56BHKD1.60B · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.07xvs Medical Devices peers
Current Ratio (MRQ)
1.45xvs Medical Devices peers
Book Value per Share (MRQ)
4.03HKDUpdated Aug 19, 2026Total Assets
3.70BUSDvs all stocks (USD)
Total Current Assets
1.63BUSDFY2025 · Dec 31, 2025Total Liabilities
2.20BUSDFY2025 · Dec 31, 2025Total Non-current Assets
2.06BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
1.07BUSDFY2025 · Dec 31, 2025Total Current Liabilities
1.13BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
682.51MUSDFY2025 · Dec 31, 2025Other Short-term Investments
128.04MUSDFY2025 · Dec 31, 2025Accounts Receivable
328.07MUSDFY2025 · Dec 31, 2025Inventory
349.20MUSDFY2025 · Dec 31, 2025Accounts Payable
176.65MUSDFY2025 · Dec 31, 2025Short-term Debt
651.13MUSDFY2025 · Dec 31, 2025Long-term Debt
949.62MUSDFY2025 · Dec 31, 2025Common Stock (Book)
19.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-1.55BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
1.50BUSDvs all stocks (USD)
52-Week Low
5.83HKDUpdated Aug 19, 202652-Week High
16.28HKDUpdated Aug 19, 202652-Week Change
-50.99%vs all stocks
Beta
0.3620xvs all stocks
50-Day MA
6.73HKDUpdated Aug 19, 2026200-Day MA
9.37HKDUpdated Aug 19, 2026Avg 10-Day Volume
12.80MSharesUpdated Aug 19, 2026Avg 30-Day Volume
11.59MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-1.01HKDUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.46: distress zoneCritical
Altman Z-Score: 0.46
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $2.64B, above the global median of $1.15BNotable
Market cap (USD): 2,639,026,120.834Global Median: 1,146,734,693.424
Revenue is $1.11B, above the global median of $520.53MNotable
Revenue (USD): 1,105,778,055.082Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Sinocelltech Group Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
AtaiBeckley Inc.
Tier 1ProductionApproval-Gated PipelineRule
Tarsus Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Kodiak Sciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Maravai Lifesciences Holdings Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sellas Life Sciences Group Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Ligachem Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Trevi Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Guangzhou Innogen Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
TransMedics Group Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule